<DOC>
	<DOCNO>NCT01694953</DOCNO>
	<brief_summary>This multi-center natural history study MNGIE ( Mitochondrial NeurogastroIntestinal Encephalopathy ) . Patients follow time assess clinical symptom . The investigator hope learn disease MNGIE well develop useful measure disease status use future clinical trial . Additional clinical center list become available .</brief_summary>
	<brief_title>The Natural History Study Mitochondrial NeuroGastroIntestinal Encephalopathy ( MNGIE )</brief_title>
	<detailed_description>The investigator examine total 20 patient six month interval five year . The investigator evaluate gastrointestinal function , lean body mass , neuropathy , neuropsychological capability , quality life , nutrition , motor function biochemical parameter .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<criteria>1 . Thymidine Phosphorylase ( TP ) defect : 1. homozygous 2. compound heterozygous mutation TYMP gene , and/or 3 . TP enzyme activity &lt; 20 % normal . 2 . Increased plasma Thd &gt; 3 micromole/L 3 . Increased plasma dUrd &gt; 7.5 micromole/L 4 . Age requirement least 5 year age . 1 . Participation interventional ( study medication experimental intervention ) study ( within 1 month participation study ) . 2 . Unable travel site research visit . 3 . Unwillingness sign inform consent form . 4 . Substance abuser</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>MNGIE</keyword>
	<keyword>Mitochondrial</keyword>
	<keyword>Mitochondrial Neurogastrointestinal encephalopathy</keyword>
</DOC>